Milestone Pharmaceuticals Inc
MIST
Company Profile
Business description
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
Contact
1111 Dr. Frederik-Phillips Boulevard
Suite 420
MontrealQCH4M 2X6
CANT: +1 514 336-0444
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
38
Stocks News & Analysis
stocks
ASX payments utility looks overvalued
Australia’s invisible payments utility earns narrow moat yet valuation looks lofty.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,823.20 | 71.40 | -0.80% |
| CAC 40 | 7,729.69 | 39.52 | -0.51% |
| DAX 40 | 24,806.97 | 297.39 | -1.18% |
| Dow JONES (US) | 51,136.38 | 43.49 | -0.08% |
| FTSE 100 | 10,441.60 | 16.90 | -0.16% |
| HKSE | 23,785.79 | 344.71 | -1.43% |
| NASDAQ | 27,109.53 | 429.16 | -1.56% |
| Nikkei 225 | 69,042.11 | 993.60 | -1.42% |
| NZX 50 Index | 13,691.85 | 7.81 | 0.06% |
| S&P 500 | 7,742.95 | 58.82 | -0.75% |
| S&P/ASX 200 | 8,660.90 | 66.80 | -0.77% |
| SSE Composite Index | 3,811.90 | 30.29 | -0.79% |